These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7985435)

  • 21. Control of heifer mastitis: antimicrobial treatment-an overview.
    Nickerson SC
    Vet Microbiol; 2009 Feb; 134(1-2):128-35. PubMed ID: 18963599
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of probiotic and antibiotic intramammary therapy of cattle with elevated somatic cell counts.
    Greene WA; Gano AM; Smith KL; Hogan JS; Todhunter DA
    J Dairy Sci; 1991 Sep; 74(9):2976-81. PubMed ID: 1779053
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibiotic treatment of mastitis: comparison of intramammary and intramammary plus intramuscular therapies.
    Owens WE; Watts JL; Boddie RL; Nickerson SC
    J Dairy Sci; 1988 Nov; 71(11):3143-7. PubMed ID: 3230193
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recombinant bovine interleukin-2 and dry cow therapy: efficacy to cure and prevent intramammary infections, safety, and effect on gestation.
    Erskine RJ; Bartlett PC; Tavernier SR; Fowler LH; Walker RD; Seguin JH; Shuster D
    J Dairy Sci; 1998 Jan; 81(1):107-15. PubMed ID: 9493085
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparative field trial of cephalonium and cloxacillin for dry cow therapy for mastitis in Australian dairy cows.
    Shephard RW; Burman S; Marcun P
    Aust Vet J; 2004 Oct; 82(10):624-9. PubMed ID: 15887388
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early-lactation extended pirlimycin therapy against naturally acquired Staphylococcus aureus intramammary infections in heifers: A randomized controlled trial.
    Skoulikas S; Dufour S; Haine D; Perreault JY; Roy JP
    J Dairy Sci; 2018 Feb; 101(2):1419-1427. PubMed ID: 29224881
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of intramammary tilmicosin and risk factors for cure of Staphylococcus aureus infection in the dry period.
    Dingwell RT; Leslie KE; Duffield TF; Schukken YH; DesCoteaux L; Keefe GP; Kelton DF; Lissemore KD; Shewfelt W; Dick P; Bagg R
    J Dairy Sci; 2003 Jan; 86(1):159-68. PubMed ID: 12613861
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of the use of dry cow antibiotics in low somatic cell count cows.
    Scherpenzeel CG; den Uijl IE; van Schaik G; Olde Riekerink RG; Keurentjes JM; Lam TJ
    J Dairy Sci; 2014; 97(6):3606-14. PubMed ID: 24746132
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nonlactating-cow therapy with a formulation of penicillin and novobiocin: therapeutic and prophylactic effects.
    Schultze WD; Mercer HD
    Am J Vet Res; 1976 Nov; 37(11):1275-9. PubMed ID: 984557
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lysostaphin: use of a recombinant bactericidal enzyme as a mastitis therapeutic.
    Oldham ER; Daley MJ
    J Dairy Sci; 1991 Dec; 74(12):4175-82. PubMed ID: 1787188
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of prepartum intramammary treatment with pirlimycin hydrochloride on prevalence of early first-lactation mastitis in dairy heifers.
    Middleton JR; Timms LL; Bader GR; Lakritz J; Luby CD; Steevens BJ
    J Am Vet Med Assoc; 2005 Dec; 227(12):1969-74. PubMed ID: 16379636
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Efficacy of a modified formula dry cow preparation for dairy cattle containing 600 mg cloxacillin].
    Sol J; Melenhorst A
    Tijdschr Diergeneeskd; 1990 Jul; 115(14):670-3. PubMed ID: 2375025
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The selective treatment of clinical mastitis based on on-farm culture results: I. Effects on antibiotic use, milk withholding time, and short-term clinical and bacteriological outcomes.
    Lago A; Godden SM; Bey R; Ruegg PL; Leslie K
    J Dairy Sci; 2011 Sep; 94(9):4441-56. PubMed ID: 21854917
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of intramammary tilmicosin infusion as a dry cow therapy.
    Mohammadsadegh M
    J Vet Pharmacol Ther; 2018 Feb; 41(1):22-27. PubMed ID: 28600854
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors affecting cure and somatic cell count after pirlimycin treatment of subclinical mastitis in lactating cows.
    Deluyker HA; Van Oye SN; Boucher JF
    J Dairy Sci; 2005 Feb; 88(2):604-14. PubMed ID: 15653527
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of nisin in treatment of clinical mastitis in lactating dairy cows.
    Cao LT; Wu JQ; Xie F; Hu SH; Mo Y
    J Dairy Sci; 2007 Aug; 90(8):3980-5. PubMed ID: 17639009
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The use of a cephalonium containing dry cow therapy and an internal teat sealant, both alone and in combination.
    Bradley AJ; Breen JE; Payne B; Williams P; Green MJ
    J Dairy Sci; 2010 Apr; 93(4):1566-77. PubMed ID: 20338434
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mastitis prevalence in primigravid heifers at parturition.
    Pankey JW; Drechsler PA; Wildman EE
    J Dairy Sci; 1991 May; 74(5):1550-2. PubMed ID: 1880264
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Technical note: Development of a challenge model for Streptococcus uberis mastitis in dairy heifers.
    Jackson KA; Nickerson SC; Kautz FM; Hurley DJ
    J Dairy Sci; 2012 Dec; 95(12):7210-3. PubMed ID: 23040028
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potentiation of antibiotic therapy for bovine mastitis by recombinant bovine interleukin-2.
    Daley MJ; Furda G; Dougherty R; Coyle PA; Williams TJ; Johnston P
    J Dairy Sci; 1992 Dec; 75(12):3330-8. PubMed ID: 1474202
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.